Contact Us
Drug Search Results
More Filters [+]

Lanicemine

Alternative Names: lanicemine, azd6765, BHV5500, BHV-5500, azd-6765
Latest Update: 2023-05-25
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: NMDA Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: AstraZeneca
Company Location: CAMBRIDGE X0 CB2 0AA
Company CEO: Pascal Soriot
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lanicemine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Depressive Disorder, Major|Depressive Disorder, Treatment-Resistant

Phase 1: Depressive Disorder, Major|Healthy Volunteers|Stress Disorders, Post-Traumatic|Depressive Disorder

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
1R61MH110540-01

P1

Completed

Stress Disorders, Post-Traumatic|Depressive Disorder

2019-11-12

D6702C00031

P2

Completed

Depressive Disorder, Major

2013-08-26

2011-004690-87

P2

Completed

Depressive Disorder, Major

2013-08-23

D6702C00015

P2

Completed

Depressive Disorder, Major|Depressive Disorder, Treatment-Resistant

2011-12-01

Recent News Events

Date

Type

Title

05/25/2023

PubMed

 Binding Affinity and Mechanisms of Potential Antidepressants Targeting Human NMDA Receptors.

08/24/2022

PubMed

 Combined hyperforin and lanicemine treatment instead of ketamine or imipramine restores behavioral deficits induced by chronic restraint stress and dietary zinc restriction in mice.

07/01/2022

PubMed

 Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials.

02/11/2021

News Article

 Psychedelics are Gaining Traction as Therapies and Medicines

01/12/2021

News Article

 Researchers Seek to Better Understand Psychedelics' Role in New Therapies

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions